Savara Pharmaceuticals Inc. CEO Rob Neville told BioWorld Today that $20 million in series C money will "get us at least to the first patient and beyond, but not all the way through" the pivotal phase ...

AUSTIN, Texas, June 12, 2012 /PRNewswire via COMTEX/ -- Savara Pharmaceuticals, an emerging specialty pharmaceutical company developing innovative pulmonary drugs for the treatment of serious and life ...

Savara Pharmaceuticals' AeroVanc Granted U.S. Orphan Drug Designation for the Treatment of MRSA Lung Infection in Cystic Fibrosis Patients AUSTIN, Texas, Nov. 13, 2012 -- /PRNewswire/ -- Savara ...

Savara Pharmaceuticals announced that the FDA has granted orphan drug status to AeroVanc (vancomycin hydrochloride inhalation powder) for the treatment of pulmonary methicillin-resistant ...

Vancomycin flushing syndrome (VFS) is a reaction to the antibiotic drug vancomycin. Common symptoms consist of a rash that itches during or after the infusion of vancomycin. VFS is the most common ...

COPENHAGEN, Denmark & BUFFALO GROVE, IL.--(BUSINESS WIRE)--Xellia Pharmaceuticals (‘Xellia’), a global leader in the manufacturing of specialty anti-infective treatments, announced today it has ...

Purpose. The feasibility of using a limitedsampling algorithm for administration of vancomycin for treatment of vascular-access-related bacteremia in outpatient high flux hemodialysis was investigated ...

• Savara Pharmaceuticals, of Austin, Texas, reported top-line data from its Phase Ia study of AeroVanc, an inhaled antibiotic. AeroVanc (vancomycin hydrochloride inhalation powder) is a dry powder ...

Antimicrobial resistance is one of the great crises of the 21st century, and Staphylococcus aureus is an important bacteria species leading this charge. In 2019, for example, methicillin-resistant ...

April 29, 2004 — Last month, the U.S. Food and Drug Administration (FDA) approved revisions to safety labeling for metformin HCl, lisinopril, lisinopril-hydrochlorothiazide, fluticasone propionate, ...